{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T11:06:45Z","timestamp":1770894405102,"version":"3.50.1"},"reference-count":33,"publisher":"e-Century Publishing Corporation","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/nagl6201","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T08:26:39Z","timestamp":1762763199000},"page":"8243-8264","source":"Crossref","is-referenced-by-count":1,"title":["PLXND1 from the Plexins family is a prognostic factor promoting colon cancer invasion and metastasis"],"prefix":"10.62347","volume":"17","author":[{"given":"Wenxing","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I and Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024; 74: 229-263.","journal-title":"CA Cancer J Clin"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3322\/caac.21766","article-title":"Interventional gastroenterology in oncology","volume":"73","author":"Wadhwa","year":"2023","unstructured":"Wadhwa V, Patel N, Grover D, Ali FS and Thosani N. Interventional gastroenterology in oncology. CA Cancer J Clin 2023; 73: 286-319.","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"4046","DOI":"10.3390\/cancers15164046","article-title":"Plexins as regulators of cancer cell proliferation, migration, and invasivity","volume":"15","author":"Toledano","year":"2023","unstructured":"Toledano S and Neufeld G. Plexins as regulators of cancer cell proliferation, migration, and invasivity. Cancers (Basel) 2023; 15: 4046.","journal-title":"Cancers (Basel)"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.molmed.2023.07.009","article-title":"Mind the (guidance) signals! Translational relevance of semaphorins, plexins, and neuropilins in pancreatic cancer","volume":"29","author":"Fard","year":"2023","unstructured":"Fard D, Giraudo E and Tamagnone L. Mind the (guidance) signals! Translational relevance of semaphorins, plexins, and neuropilins in pancreatic cancer. Trends Mol Med 2023; 29: 817-829.","journal-title":"Trends Mol Med"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Limoni G and Niquille M. Semaphorins and Plexins in central nervous system patterning: the key to it all? Curr Opin Neurobiol 2021; 66: 224-232.","DOI":"10.1016\/j.conb.2020.12.014"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1038\/s41388-024-03081-6","article-title":"Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancer","volume":"43","author":"Chen","year":"2024","unstructured":"Chen B, Xu P, Yang JC, Nip C, Wang L, Shen Y, Ning S, Shang Y, Corey E, Gao AC, Gestwicki JE, Wei Q, Liu L and Liu C. Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancer. Oncogene 2024; 43: 2325-2337.","journal-title":"Oncogene"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1158\/2326-6066.CIR-23-0289","article-title":"PlexinB1 Inactivation Reprograms Immune Cells in the Tumor Microenvironment, Inhibiting Breast Cancer Growth and Metastatic Dissemination","volume":"12","author":"Franzolin","year":"2024","unstructured":"Franzolin G, Brundu S, Cojocaru CF, Curatolo A, Ponzo M, Mastrantonio R, Mihara E, Kumanogoh A, Suga H, Takagi J, Tamagnone L and Giraudo E. PlexinB1 Inactivation Reprograms Immune Cells in the Tumor Microenvironment, Inhibiting Breast Cancer Growth and Metastatic Dissemination. Cancer Immunol Res 2024; 12: 1286-1301.","journal-title":"Cancer Immunol Res"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12929-024-01074-x","article-title":"Plexin C1 influences immune response to intracellular LPS and survival in murine sepsis","volume":"31","author":"Bernard","year":"2024","unstructured":"Bernard A, Eggstein C, Tang L, Keller M, K&#xF6;rner A, Mirakaj V and Rosenberger P. Plexin C1 influences immune response to intracellular LPS and survival in murine sepsis. J Biomed Sci 2024; 31: 82.","journal-title":"J Biomed Sci"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"101047","DOI":"10.1016\/j.neo.2024.101047","article-title":"PLXNA1 confers enzalutamide resistance in prostate cancer via AKT signaling pathway","volume":"57","author":"Hu","year":"2024","unstructured":"Hu J, Zhang J, Han B, Qu Y, Zhang Q, Yu Z, Zhang L, Han J, Liu H, Gao L, Feng T, Dou B, Chen W and Sun F. PLXNA1 confers enzalutamide resistance in prostate cancer via AKT signaling pathway. Neoplasia 2024; 57: 101047.","journal-title":"Neoplasia"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41419-023-05554-0","article-title":"Plexin-A2 enables the proliferation and the development of tumors from glioblastoma derived cells","volume":"14","author":"Toledano","year":"2023","unstructured":"Toledano S, Sabag AD, Ilan N, Liburkin-Dan T, Kessler O and Neufeld G. Plexin-A2 enables the proliferation and the development of tumors from glioblastoma derived cells. Cell Death Dis 2023; 14: 41.","journal-title":"Cell Death Dis"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"112164","DOI":"10.1016\/j.celrep.2023.112164","article-title":"Plexin-B3 expression stimulates MET signaling, breast cancer stem cell specification, and lung metastasis","volume":"42","author":"Zuo","year":"2023","unstructured":"Zuo Q, Yang Y, Lyu Y, Yang C, Chen C, Salman S, Huang TY, Wicks EE, Jackson W 3rd, Datan E, Qin W and Semenza GL. Plexin-B3 expression stimulates MET signaling, breast cancer stem cell specification, and lung metastasis. Cell Rep 2023; 42: 112164.","journal-title":"Cell Rep"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Moreno P, Fexova S, George N, Manning JR, Miao Z, Mohammed S, Mu&#xF1;oz-Pomer A, Fullgrabe A, Bi Y, Bush N, Iqbal H, Kumbham U, Solovyev A, Zhao L, Prakash A, Garc&#xED;a-Seisdedos D, Kundu DJ, Wang S, Walzer M, Clarke L, Osumi-Sutherland D, Tello-Ruiz MK, Kumari S, Ware D, Eliasova J, Arends MJ, Nawijn MC, Meyer K, Burdett T, Marioni J, Teichmann S, Vizca&#xED;no JA, Brazma A and Papatheodorou I. Expression Atlas update: gene and protein expression in multiple species. Nucleic Acids Res 2022; 50: D129-D140.","DOI":"10.1093\/nar\/gkab1030"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","article-title":"Determining cell type abundance and expression from bulk tissues with digital cytometry","volume":"37","author":"Newman","year":"2019","unstructured":"Newman AM, Steen CB, Liu CL, Gentles AJ, Chaudhuri AA, Scherer F, Khodadoust MS, Esfahani MS, Luca BA, Steiner D, Diehn M and Alizadeh AA. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol 2019; 37: 773-782.","journal-title":"Nat Biotechnol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.7150\/ijms.101043","article-title":"CDK6 as a biomarker for immunotherapy, drug sensitivity, and prognosis in bladder cancer: bioinformatics and immunohistochemical analysis","volume":"21","author":"Zhao","year":"2024","unstructured":"Zhao X, Yu X, Li W, Chen Z, Niu T, Weng X, Wang L and Liu X. CDK6 as a biomarker for immunotherapy, drug sensitivity, and prognosis in bladder cancer: bioinformatics and immunohistochemical analysis. Int J Med Sci 2024; 21: 2414-2429.","journal-title":"Int J Med Sci"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Tissue-based map of the human proteome","volume":"347","author":"Uhl&#xE9","year":"2015","unstructured":"Uhl&#xE9;n M, Fagerberg L, Hallstr&#xF6;m BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson &#xC5;, Kampf C, Sj&#xF6;stedt E, Asplund A, Olsson I, Edlund K, Lundberg E, Navani S, Szigyarto CA, Odeberg J, Djureinovic D, Takanen JO, Hober S, Alm T, Edqvist PH, Berling H, Tegel H, Mulder J, Rockberg J, Nilsson P, Schwenk JM, Hamsten M, von Feilitzen K, Forsberg M, Persson L, Johansson F, Zwahlen M, von Heijne G, Nielsen J and Pont&#xE9;n F. Proteomics. Tissue-based map of the human proteome. Science 2015; 347: 1260419.","journal-title":"Science"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003; 13: 2498-504.","journal-title":"Genome Res"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41586-024-07715-3","article-title":"In vivo interaction screening reveals liver-derived constraints to metastasis","volume":"632","author":"Borrelli","year":"2024","unstructured":"Borrelli C, Roberts M, Eletto D, Hussherr MD, Fazilaty H, Valenta T, Lafzi A, Kretz JA, Guido Vinzoni E, Karakatsani A, Adivarahan S, Mannhart A, Kimura S, Meijs A, Baccouche Mhamedi F, Acar IE, Handler K, Ficht X, Platt RJ, Piscuoglio S and Moor AE. In vivo interaction screening reveals liver-derived constraints to metastasis. Nature 2024; 632: 411-418.","journal-title":"Nature"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"5536","DOI":"10.3390\/cancers15235536","article-title":"Semaphorin 6 family-an important yet overlooked group of signaling proteins involved in cancerogenesis","volume":"15","author":"Wagner","year":"2023","unstructured":"Wagner W, Ochman B and Wagner W. Semaphorin 6 family-an important yet overlooked group of signaling proteins involved in cancerogenesis. Cancers (Basel) 2023; 15: 5536.","journal-title":"Cancers (Basel)"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1158\/1541-7786.MCR-23-0836","article-title":"B-type Plexins Regulate Mitosis via RanGTPase","volume":"23","author":"Mukhwana","year":"2025","unstructured":"Mukhwana N, Garg R, Azad A, Mitchell AR and Williamson M. B-type Plexins Regulate Mitosis via RanGTPase. Mol Cancer Res 2025; 23: 8-19.","journal-title":"Mol Cancer Res"},{"key":"ref19","unstructured":"Hung YH, Hou YC, Hsu SH, Wang LY, Tsai YL, Shan YS, Su YY, Hung WC and Chen LT. Pancreatic cancer cell-derived semaphorin 3A promotes neuron recruitment to accelerate tumor growth and dissemination. Am J Cancer Res 2023; 13: 3417-3432."},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Li CX, Long D and Meng Q. Promising therapeutic targets in kidney renal clear cell carcinoma: PLXNA1 and PLXNB3. Cancer Biother Radiopharm 2024; 39: 276-290.","DOI":"10.1089\/cbr.2021.0336"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1297354","DOI":"10.3389\/fimmu.2023.1297354","article-title":"Plexin B1 controls Treg numbers, limits allergic airway inflammation, and regulates mucins","volume":"14","author":"Chapoval","year":"2024","unstructured":"Chapoval SP, Gao H, Fanaroff R and Keegan AD. Plexin B1 controls Treg numbers, limits allergic airway inflammation, and regulates mucins. Front Immunol 2024; 14: 1297354.","journal-title":"Front Immunol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1158\/2326-6066.CIR-21-0061","article-title":"Plexin-A4 mediates cytotoxic T-cell trafficking and exclusion in cancer","volume":"10","author":"Celus","year":"2022","unstructured":"Celus W, Oliveira AI, Rivis S, Van Acker HH, Landeloos E, Serneels J, Cafarello ST, Van Herck Y, Mastrantonio R, K&#xF6;hler A, Garg AD, Flamand V, Tamagnone L, Marine JC, Di Matteo M, Costa BM, Bechter O and Mazzone M. Plexin-A4 mediates cytotoxic T-cell trafficking and exclusion in cancer. Cancer Immunol Res 2022; 10: 126-141.","journal-title":"Cancer Immunol Res"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"107164","DOI":"10.1016\/j.intimp.2020.107164","article-title":"Molecular subtypes based on immune-related genes predict the prognosis for hepatocellular carcinoma patients","volume":"90","author":"Hu","year":"2021","unstructured":"Hu B, Yang XB and Sang XT. Molecular subtypes based on immune-related genes predict the prognosis for hepatocellular carcinoma patients. Int Immunopharmacol 2021; 90: 107164.","journal-title":"Int Immunopharmacol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41571-024-00870-6","article-title":"Regulatory T cell-mediated immunosuppression orchestrated by cancer: towards an immuno-genomic paradigm for precision medicine","volume":"21","author":"Kumagai","year":"2024","unstructured":"Kumagai S, Itahashi K and Nishikawa H. Regulatory T cell-mediated immunosuppression orchestrated by cancer: towards an immuno-genomic paradigm for precision medicine. Nat Rev Clin Oncol 2024; 21: 337-353.","journal-title":"Nat Rev Clin Oncol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12943-023-01714-0","article-title":"Regulatory cells and the effect of cancer immunotherapy","volume":"22","author":"Iglesias-Escudero M","year":"2023","unstructured":"Iglesias-Escudero M, Arias-Gonz&#xE1;lez N and Mart&#xED;nez-C&#xE1;ceres E. Regulatory cells and the effect of cancer immunotherapy. Mol Cancer 2023; 22: 26.","journal-title":"Mol Cancer"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"5530","DOI":"10.3390\/cancers15235530","article-title":"Analysis of the tumor immune microenvironment (TIME) in clear cell renal cell carcinoma (ccRCC) reveals an M0 macrophage-enriched subtype: an exploration of prognostic and biological characteristics of this immune phenotype","volume":"15","author":"Farha","year":"2023","unstructured":"Farha M, Nallandhighal S, Vince R, Cotta B, Stangl-Kremser J, Triner D, Morgan TM, Palapattu GS, Cieslik M, Vaishampayan U, Udager AM and Salami SS. Analysis of the tumor immune microenvironment (TIME) in clear cell renal cell carcinoma (ccRCC) reveals an M0 macrophage-enriched subtype: an exploration of prognostic and biological characteristics of this immune phenotype. Cancers (Basel) 2023; 15: 5530.","journal-title":"Cancers (Basel)"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/ijc.34986","article-title":"Associations between eosinophils and cancer risk in the UK Biobank","volume":"155","author":"Wang","year":"2024","unstructured":"Wang JH, Rabkin CS, Engels EA and Song M. Associations between eosinophils and cancer risk in the UK Biobank. Int J Cancer 2024; 155: 486-492.","journal-title":"Int J Cancer"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"604131","DOI":"10.3389\/fonc.2020.604131","article-title":"Prognostic value of PLXND1 and TGF-&#x3B2;1 coexpression and its correlation with immune infiltrates in hepatocellular carcinoma","volume":"10","author":"Li","year":"2021","unstructured":"Li J, Hu K, He D, Zhou L, Wang Z and Tao Y. Prognostic value of PLXND1 and TGF-&#x3B2;1 coexpression and its correlation with immune infiltrates in hepatocellular carcinoma. Front Oncol 2021; 10: 604131.","journal-title":"Front Oncol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fonc.2020.00033","article-title":"PLXNC1 enhances carcinogenesis through transcriptional activation of IL6ST in gastric cancer","volume":"10","author":"Chen","year":"2020","unstructured":"Chen J, Liu H, Chen J, Sun B, Wu J and Du C. PLXNC1 enhances carcinogenesis through transcriptional activation of IL6ST in gastric cancer. Front Oncol 2020; 10: 33.","journal-title":"Front Oncol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"7396","DOI":"10.3390\/ijms21197396","article-title":"A SEMA3 signaling pathway-based multi-biomarker for prediction of glioma patient survival","volume":"21","author":"Valiulyte","year":"2020","unstructured":"Valiulyte I, Steponaitis G, Kardonaite D, Tamasauskas A and Kazlauskas A. A SEMA3 signaling pathway-based multi-biomarker for prediction of glioma patient survival. Int J Mol Sci 2020; 21: 7396.","journal-title":"Int J Mol Sci"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12885-023-10526-w","article-title":"Notch3 signaling promotes colorectal tumor growth by enhancing immunosuppressive cells infiltration in the microenvironment","volume":"23","author":"Huang","year":"2023","unstructured":"Huang K, Luo W, Fang J, Yu C, Liu G, Yuan X, Liu Y and Wu W. Notch3 signaling promotes colorectal tumor growth by enhancing immunosuppressive cells infiltration in the microenvironment. BMC Cancer 2023; 23: 55.","journal-title":"BMC Cancer"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1430352","DOI":"10.3389\/fimmu.2024.1430352","article-title":"Exploiting branched-chain amino acid metabolism and Notch3 expression to predict and target colorectal cancer progression","volume":"15","author":"Shen","year":"2024","unstructured":"Shen K, Zhu C, Wu J, Yan J, Li P, Cao S, Zhou X and Yao G. Exploiting branched-chain amino acid metabolism and Notch3 expression to predict and target colorectal cancer progression. Front Immunol 2024; 15: 1430352.","journal-title":"Front Immunol"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/10\/ajtr0161837.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T03:15:39Z","timestamp":1769138139000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/10\/ajtr0161837.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":33,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/nagl6201","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}